JPT Peptide Technologies

CDMO

Germany

https://www.jpt.com/

Is this your company? Claim this profile

Drug Product

Analytical & Bioanalytical Services

Company Overview

About

JPT Peptide Technologies is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines

Therapeutic Areas

Respiratory

Allergy

Quick Facts

HQ:Germany

Founded:2000

Employees:1,345

Capabilities & Services

Core Capabilities

Biologics Drug Substance
Biologics Manufacturing
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Sterile Injectable

Containment Capabilities

OEB 4 (1-10 µg/m³)

Production Scales

Phase II

Clinical

Pilot Scale

Markets Served

Global

Regulatory Approvals

Drug Approval UIVAMK

FDA · #APR-3G16UY8G · 2020-03-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

WHO GMP

World Health Organization

Cert #: CERT-M3IIJJXV

Issued: 2020-11-24

Expires: 2025-12-14

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-MHHKE3HL

Issued: 2020-10-21

Expires: 2025-07-04

Health Canada GMP

Health Canada

Cert #: CERT-8W7DWFMJ

Issued: 2020-07-05

Expires: 2025-08-11

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about JPT Peptide Technologies

JPT Peptide Technologies is headquartered in Germany.
JPT Peptide Technologies was founded in 2000.
JPT Peptide Technologies has 1,345 employees.
JPT Peptide Technologies's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.

Find CDMOs like JPT Peptide Technologies

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Germany CDMOs in Europe Biologics Drug Substance CDMOs Formulation Development CDMOs Sterile Injectable CDMOs OEB 4 (1-10 µg/m³) CDMOs